1. Salvinorin A reduces neuropathic nociception in the insular cortex of the rat.
- Author
-
Coffeen U, Canseco-Alba A, Simón-Arceo K, Almanza A, Mercado F, León-Olea M, and Pellicer F
- Subjects
- Animals, Diterpenes, Clerodane therapeutic use, Male, Narcotic Antagonists pharmacology, Rats, Rats, Wistar, Receptor, Cannabinoid, CB1 agonists, Receptor, Cannabinoid, CB1 antagonists & inhibitors, Receptors, Opioid, kappa agonists, Cerebral Cortex drug effects, Diterpenes, Clerodane pharmacology, Neuralgia drug therapy, Nociception drug effects
- Abstract
Background: Neuropathic pain is one of the most important challenges in public health. The search for novel treatments is important for an adequate relief without adverse effects. In this sense salvinorin A (SA), the main diterpene of the medicinal plant Salvia divinorum is an important antinociceptive compound, which acts as a potent agonist of kappa opioid receptor (KOR) and cannabinoid CB1 receptors., Methods: We evaluated nociceptive responses in a neuropathic pain model induced by the sciatic nerve ligature (SNL) in the right hind paw, after the microinjection of SA, Salvinorin B (SB), KOR and CB1 antagonists directly in the insular cortex (IC) in male wistar rats., Results: We found a potent antinociceptive effect with the administration of SA. Moreover, this effect was blocked by the administration of a KOR antagonist as well as the administration of a CB1 antagonist., Conclusion: Salvinorin A has a potent antinociceptive effect when is administered centrally in the IC by the interaction with KOR and CB1 receptors., Significance: We show evidence on the effectiveness of the administration of salvinorin A in the IC in a rodent model of neuropathic pain. These results support the use of novel compounds like SA as a therapeutic alternative for neuropathic pain relief., (© 2017 European Pain Federation - EFIC®.)
- Published
- 2018
- Full Text
- View/download PDF